Evidence map›Paper›PMID 27845239›Full record

ReviewNeuroscience letters2017

Circuit dysregulation and circuit-based treatments in posttraumatic stress disorder.

Jony Sheynin, Israel Liberzon

Registry-linked trialAbstract readReview
In one paragraph

Review in Neuroscience letters, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06036511 (Connectivity Changes Associated With Ketamine Assisted Psychotherapy for PTSD), which is not on this map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06036511 phase1 / phase2withdrawnnot on this mapstarted 2023, after this paper: background citation

Connectivity Changes Associated With Ketamine Assisted Psychotherapy for PTSD

TypeinterventionalSponsorUniversity of New MexicoRan2023 to 2023Enrolled0ConditionsPTSDArmsKetamine Hydrochloride
3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Neuroimaging correlates and predictors of response to repeated-dose intravenous ketamine in PTSD: preliminary evidence.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2021
    Trial
  4. Trial
  5. Trial
  6. Trial
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Neural correlates of conceptual-level fear generalization in posttraumatic stress disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2020
    Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jony SheyninVeterans Affairs Ann Arbor Healthcare System and Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA. Electronic address: jsheynin@med.umich.edu.
Israel LiberzonVeterans Affairs Ann Arbor Healthcare System and Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA. Electronic address: liberzon@med.umich.edu.

Funding

Cognition-Emotion-HPA Interaction: Translation NetworkR24MH075999 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LIBERZON, ISRAEL · 2006 to 2008
$1.1M
NIMH NIH HHS R24 MH075999
6 · The paper itself

Abstract

Posttraumatic stress disorder (PTSD) is a psychiatric disorder that develops in some individuals in the aftermath of exposure to traumatic events, such as actual or threatened death, serious injury or sexual assault. It has been hypothesized that dysregulations in a number of specific neurocircuits, characterized by heightened responsivity of amygdala, dACC and insula, diminished responsivity of mPFC, impaired hippocampal function and deficits in cortical regions, underlie the development and expression of key PTSD symptoms. Here, we concisely describe three functional neural circuits implicated in PTSD pathophysiology and briefly review selected treatment strategies in the context of these neural circuits. We start with the commonly implicated neurocircuit model, namely, the fear learning and threat detection circuits, and then discuss the context processing circuitry, which plays an important role among others, in fear regulation. We then discuss the emotion regulation circuitry, which can further contribute to PTSD pathophysiology, and conclude with a discussion of the therapeutic approaches that might be targeting dysregulation in these circuits in PTSD patients. Specifically, we discuss how exposure-based treatments might be targeting fear learning circuits, and the pharmacological and brain-stimulation interventions aimed to augment these therapies. Finally, we discuss other pharmacological and cognitive therapeutic approaches that can augment or restore the function of the context processing and emotional regulation circuits.

Indexed as

AmygdalaAnimalsBrainConditioning, ClassicalEmotionsFearHippocampusHumansNeural PathwaysPrefrontal CortexStress Disorders, Post-TraumaticCircuit- based treatmentsCircuit dysregulationPosttraumatic stress disorder

Identifiers

PMID27845239
PMCPMC5422122

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.